ST. LOUIS — Sigma-Aldrich Corporation (NASDAQ: SIAL), a leading Life Science and High Technology company (the “Company”), announced today at its 2013 Annual Shareholders Meeting that the Company’s Board of Directors approved a quarterly cash dividend of $0.215 per share. The dividend is payable on June 14, 2013 to shareholders of record on May 31, […]
ALAMEDA, Calif. — BioTime, Inc. (NYSE MKT: BTX) and subsidiary, LifeMap Sciences, today announced the release of the enhanced LifeMap BioReagents™ portal (https://bioreagents.lifemapsc.com/) featuring an improved user interface, product descriptions, and customer support options, as well as the addition of new PureStem™ progenitor cells to the site. These novel progenitors provide new and unique tools […]
Austin, TX — Bioo Scientific introduces the NEXTflex™ qRNA-Seq™ Kit for high precision gene expression analysis by RNA-Seq. Developed in conjunction with Cellular Research Inc., this new kit efficiently generates libraries equivalent to conventional RNA-Seq libraries, but with the added feature of Molecular Indexing™ technology. Similar to conventional RNA-Seq, sample RNA is converted to cDNA […]
Solon, Ohio — DNA quantitation is crucial to experimental design and interpretation of results, especially in sensitive molecular biology applications such as PCR, or for any comparative analysis of multi-source DNA samples. Although UV spectrophotometric measurement at 260 nm is the most widely practiced method of DNA quantitation, it is limited by high background interference […]
Lucigen Corporation and Research Corporation Technologies (RCT) today announced a partnership to commercialize and distribute the CleanColi™ Expression System, the first Escherichia coli (E. coli)-based recombinant system that lacks unwanted endotoxin. Lucigen will produce and sell kits containing CleanColi™ competent cells and provide contract research services for the CleanColi™ Expression System. Lucigen simultaneously announces the […]
AMSBIO has announced a new range of Aptamer Protein Precipitation Kits that bind with unmatched high specificity and affinity to target molecules. The new AMSBIO Aptoprecipitation (AP) / Co-aptoprecipitation (Co-AP) Kits are aptamer based protein precipitation kits designed to provide easy, quick and consistent protein precipitation. The new kits offer a range of unique characteristics […]
Venlo, the Netherlands — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced proposals for changes in the membership of the Supervisory Board that will be put forward for approval by shareholders at the next Annual General Meeting scheduled for June 26, 2013. The proposals for the composition of the Supervisory Board, who are […]
CAMBRIDGE, Mass. and SANTA CLARA, Calif. — Gen9, Inc., a pioneer in the development of scalable technologies for synthesizing genes, and Agilent Technologies (NYSE: A) today announced the closing of a $21 million strategic investment from Agilent in Gen9. Gen9 will use these funds to further invest in product development and to expand the commercial […]
AMSBIO has announced further expansion of its tissue biorepository and collection services** to now include blood products from human donors with auto-immune and neurological conditions. Whole blood, plasma, serum, PBMCs and cerebrospinal fluid samples are available from a wide variety of donors. In addition AMSBIO is now able to offer collection services of patient samples […]
Sunnyvale, California, – Molecular Devices announced today the launch of FLIPR® Calcium 6 Assay Kits, the latest addition to their extensive range of calcium assay kits to address diversified GPCR and ion channel targets. Featuring a proprietary fluorophore, the dye offers the highest quantum yield of any calcium indicator on the market, delivering the greatest […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
